LXRX Share Price

Open 10.20 Change Price %
High 10.29 1 Day -0.01 -0.10
Low 10.03 1 Week 0.00 0.00
Close 10.19 1 Month -1.02 -9.10
Volume 784328 1 Year -6.24 -37.98
52 Week High 18.00
52 Week Low 10.02
LXRX Important Levels
Resistance 2 10.43
Resistance 1 10.33
Pivot 10.17
Support 1 10.05
Support 2 9.95
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
MU 44.31 6.39%
MU 44.31 6.39%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX)

LXRX Technical Analysis 5
As on 31st Oct 2017 LXRX Share Price closed @ 10.19 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 14.70 & Strong Sell for SHORT-TERM with Stoploss of 12.69 we also expect STOCK to react on Following IMPORTANT LEVELS.
LXRX Target for November
1st Target up-side 11.48
2nd Target up-side 12.38
3rd Target up-side 13.28
1st Target down-side 8.9
2nd Target down-side 8
3rd Target down-side 7.1
LXRX Other Details
Segment EQ
Market Capital 962548544.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.lexpharma.com
LXRX Address
LXRX
8800 Technology Forest Place
The Woodlands, TX 77381
United States
Phone: 281-863-3000
Fax: 281-863-8088
LXRX Latest News
Interactive Technical Analysis Chart Lexicon Pharmaceuticals, Inc. ( LXRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Lexicon Pharmaceuticals, Inc.
LXRX Business Profile
Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon Pharmaceuticals uses its gene knockout technologies and an integrated platform of medical technologies to study the physiological and behavioral functions of almost 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets. It has five drug programs in various stages of clinical development and has advanced small molecule compounds from a number of additional drug programs into various stages of preclinical development and research. Its drug program includes LX4211, LX1032, LX1033, LX2931 and LX7101.